The efficacy of temozolomide combined with levetiracetam for glioblastoma (GBM) after surgery: a study protocol for a double-blinded and randomized controlled trial

The efficacy of temozolomide combined with levetiracetam for glioblastoma (GBM) after surgery: a study protocol for a double-blinded and randomized controlled trial

Abstract Background Temozolomide is applied as the standard chemotherapy agent in patients with glioblastoma (GBM) after surgery. However, the benefit of this treatment for patients is limited by the invasive growth of gliomas and drug resistance. There are indications from fundamental experimental...

Full description

Bibliographic Details
Main Authors: Maoyuan Sun, Ning Huang, Yihao Tao, Rong Wen, Guanjian Zhao, Xiang Zhang, Zongyi Xie, Yuan Cheng, Jinning Mao, Guodong Liu
Format: Article
Language:English
Published: BMC 2022-03-01
Series:Trials
Subjects:
Glioblastoma (GBM)
Temozolomide, Levetiracetam
Chemotherapy
Clinical trial
Online Access:https://doi.org/10.1186/s13063-022-06168-1

Internet

https://doi.org/10.1186/s13063-022-06168-1

Similar Items